Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Clofibric acidCat. No. 0825 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Chemical Name: 2-(4-Chlorophenoxy)-2-methylpropanoic acid |
Biological Activity
PPAR agonist. Antihyperlipoproteinemic.Technical Data
M.Wt:The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
References
Merck Index 12 2437.
Shepherd (1993) Mechanism of action of fibrates. Postgrad.Med.J. 69 S34. PMID: 8497455.
Forman et al (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc.Natl.Acad.Sci.U.S.A. 94 4312. PMID: 9113986.
Bishop-Bailey (2000) Peroxisome proliferator-activated receptors in the cardiovascular system. Br.J.Pharmacol. 129 823. PMID: 10696077.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: Clofibric acid, supplier, PPAR, agonists, Non-Selective, Peroxisome, Proliferator-activating, Receptors
Quick Order
Find multiple products by catalog number
Cancer Research Guide
Request your free copy
Highlights over 350 products for cancer research. Request a copy or view PDF today.
Nuclear Receptors Product Listing
Highlights over 150 products for nuclear receptors. Reserve your free copy today and be amongst the first to receive it.
New Products in this Area
High affinity PPARγ ligand; blocks Cdk5-dependent PPARγ phosphorylation
Tocris Events
Win a Kindle
5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders
June 23 - 26, 2013
Bath, UK